Contact Us    ||    Home
 
Drug Discovery

The Drug Discovery business unit was established to commercialize therapeutic products using the genetic advantages of a founder population. NewLab has two novel therapeutics in development - next generation Peptide-T drugs for a multitude of auto-immune diseases and drugs targeting HLA Cw6, a part of the human genetic sequence thought to cause the chronic disease psoriasis. Both new therapies target immune processes common to multiple prevalent autoimmune diseases and represent billion dollar opportunities.

 

 

 

 

 

 
Home Contact Us Sitemap Privacy Policy